Communicate proven potentials in Cell & Gene Therapy: Champion data-driven value proposition
Mar 21, 2024
In this webinar, senior leaders from Bayer, Sumitomo, Mustang Bio and Microvascular Therapeutics shared their visions on key trends shaping the future of CGT clinical development, revealing how they adopt a long-term perspective and analyze data strategies to achieve commercial excellence. Key takeaways from this one-hour session include:
• Data and Automation: Scale up digital capability to close the experience gap from R&D to manufacturing
• Infuse patient-centricity into every stakeholder journey and delivering continuous patient support to generate comprehensive RWE
• Leverage long-term follow up data to translate the unique values of CGT
For more content like this, including panel discussions, articles, in-depth reports & upcoming events, join thousands of pharma leaders who read our monthly Pharma Insights by Reuters Events email newsletter here.